[Heterologous antistaphylococcal gamma-globulin in the treatment of staphylococcal sepsis].

Abstract

The first experience with the immunotherapy of staphylococcal sepsis with heterologous anti-staphylococcal gamma-globulin (cozym) with a high antitoxin titer--above 200 A. E./ml--is generalized in the article. The results of the anti-staphylococcal gamma-globulin use in 19 patients are analysed. A comparative evaluation of the drug related to the donor preparation is set forth. The advantages of heterologous anti-staphylococcal gamma-globulin are grounded.

• Authors: Iu G Shubik, V I Nemchenko
• Journal: Vestnik khirurgii imeni I. I. Grekova (Vestn Khir Im I I Grek) Vol. 122 Issue 4 Pg. 46-50 (Apr 1979) ISSN: 0042-4625 [Print] Russia (Federation)
• Vernacular Title: Geterologichnyĭ protivostafilokokkovyĭ gamma-globulin v lechenii stafilokokkovogo sepsisa.
• PMID: 87058 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Antibodies, Bacterial
• Autoantibodies
• gamma-Globulins

Topics

• Adult
• Aged
• Antibodies, Bacterial (analysis)
• Autoantibodies (analysis)
• Blood Bactericidal Activity
• Clinical Trials as Topic
• Drug Evaluation
• Female
• Humans
• Male
• Middle Aged
• Postoperative Complications (drug therapy, immunology)
• Sepsis (drug therapy, immunology)
• Staphylococcal Infections (drug therapy, immunology)
• Staphylococcus (immunology)
• Time Factors
• gamma-Globulins (therapeutic use)